InvestorsHub Logo
Followers 87
Posts 1159
Boards Moderated 0
Alias Born 09/10/2017

Re: Chiugray post# 606844

Wednesday, 07/05/2023 10:51:56 PM

Wednesday, July 05, 2023 10:51:56 PM

Post# of 698803
Excellent summary Chiugray, that’s it exactly! It was a great talk by Dr. Liau with students, and I think this discussion may be easier for some non-science investors to understand, because Dr. Liau broke down very complicated scientific studies in a way that many can understand.

As you say, I think she explained very well, how dendritic cells function, how DCVax works, what their scientific studies have shown, and what they are learning about how to improve immune response going forward, to make DCVax work better. And clearly, with the incredible long-term results those combinations are showing, that will be the regimen (DCVax-L + Poly ICLC + CSF 1R inhibitor) that will be used going forward. I can’t wait for those results to be officially published, and let the world know that there is hope for Glioblastoma patients. (and Dr. Liau is a big reason why)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News